The oncologic efficacy of extended thoracic resections.

extended resection lung cancer thoracic oncology thoracic surgery

Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 10 11 2022
received: 23 10 2022
accepted: 11 11 2022
entrez: 11 1 2023
pubmed: 12 1 2023
medline: 14 1 2023
Statut: ppublish

Résumé

Locally invasive lung cancers pose unique challenges for management. Surgical resection of these tumors can pose high morbidity due to the invasion into surrounding structures, including the spine, chest wall, and great vessels. With advances in immunotherapy and chemoradiation, the role for radical resection of these malignancies and associated oncologic outcomes is evolving. This article reviews the current literature of extended thoracic resections with a focus on technical approach, functional outcomes, and oncologic efficacy.

Identifiants

pubmed: 36630102
doi: 10.1002/jso.27151
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

288-295

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Hare E. Tumor involving certain nerves. Lond Med Gaz. 1838;1:16-18.
Chmielewska I, Stencel K, Kalinka E, Ramlau R, Krawczyk P. Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer-clinical trials experience. Cancers. 2021;13(20):5048.
Bilfinger T, Keresztes R, Albano D, Nemesure B. Five-year survival among stage IIIA lung cancer patients receiving two different treatment modalities. Med Sci Monit. 2016;22:2589-2594.
Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138-155.
Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(5):497-530.
Spigel DR, Faivre-Finn C, Gray JE, et al. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. J Clin Oncol. 2022;40(12):1301-11.
Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386(21):1973-85.
DeMeester TR, Albertucci M, Dawson PJ, Montner SM. Management of tumor adherent to the vertebral column. J Thorac Cardiovasc Surg. 1989;97(3):373-378.
Grunenwald D, Mazel C, Girard P, Berthiot G, Dromer C, Baldeyrou P. Total vertebrectomy for en bloc resection of lung cancer invading the spine. Ann Thorac Surg. 1996;61(2):723-726.
Collaud S, Fadel E, Schirren J, et al. En bloc resection of pulmonary sulcus non-small cell lung cancer invading the spine: a systematic literature review and pooled data analysis. Ann Surg. 2015;262(1):184-188.
Collaud S, Waddell TK, Yasufuku K, et al. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine. J Thorac Oncol. 2013;8(12):1538-1544.
Mody GN, Bravo Iñiguez C, Armstrong K, et al. Early surgical outcomes of en bloc resection requiring vertebrectomy for malignancy invading the thoracic spine. Ann Thorac Surg. 2016;101(1):231-237. Discussion 6-7.
Doddoli C, D′Journo B, Pimpec-Barthes FL, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg. 2005;80(6):2032-2040.
Filosso PL, Sandri A, Guerrera F, et al. Primary lung tumors invading the chest wall. J Thorac Dis. 2016;8(Suppl 11):S855-S862.
Loi M, Mazzella A, Desideri I, et al. Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach. J Thorac Dis. 2020;12(1):22-30.
Tansini I. Sopra il mio nuovo processo di amputazione della mammella. Gazz Med Ital. 1906;57(57):141.
Seder CW, Rocco G. Chest wall reconstruction after extended resection. J Thorac Dis. 2016;8(Suppl 11):S863-S871.
Huber RM, De Ruysscher D, Hoffmann H, Reu S, Tufman A. Interdisciplinary multimodality management of stage III nonsmall cell lung cancer. Eur Respir Rev. 2019;28(152):190024.
Jones GD, Caso R, No JS, et al. Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall. Eur J Cardiothorac Surg. 2020;58(1):78-85.
Scarnecchia E, Liparulo V, Capozzi R, Ceccarelli S, Puma F, Vannucci J. Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome. J Thorac Dis. 2018;10(Suppl 16):S1855-S1863.
Towe CW, Servais EL, Grau-Sepulveda M, et al. Impact of chest wall resection on mortality after lung resection for non-small cell lung cancer. Ann Thorac Surg. 2021;114:2023-2031.
Tanaka Y, Hokka D, Ogawa H, et al. Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart. Gen Thorac Cardiovasc Surg. 2017;65(7):365-73.
Spaggiari L, Tessitore A, Casiraghi M, et al. Survival after extended resection for mediastinal advanced lung cancer: lessons learned on 167 consecutive cases. Ann Thorac Surg. 2013;95(5):1717-1725.
Galvaing G, Tardy MM, Cassagnes L, et al. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes. Ann Thorac Surg. 2014;97(5):1708-1713.
Galetta D, Borri A, Gasparri R, Petrella F, Spaggiari L. Surgical techniques and long-term results of pulmonary artery reconstruction in patients with lung cancer. Ann Thorac Surg. 2015;100(4):1196-1202. Discussion 202.
Ma Q, Liu D, Guo Y, et al. Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer. J Cardiothorac Surg. 2013;8:219.
Madariaga MLL, Geller A, Lanuti M, et al. Pulmonary artery resection during lung resection for malignancy. Ann Thorac Surg. 2019;108(6):1692-700.
Maurizi G, D'andrilli A, Venuta F, Rendina EA. Reconstruction of the bronchus and pulmonary artery. J Thorac Dis. 2016;8(Suppl 2):S168-180.
Pancoast HK. Superior pulmonary sulcus tumor: tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscles chairman's address. JAMA. 1932;99(17):1391-1396.
Rusch VW. Management of pancoast tumours. Lancet Oncol. 2006;7(12):997-1005.
Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg. 2001;121(3):472-483.
Court C, Boulate D, Missenard G, Mercier O, Fadel E, Bouthors C. Video-Assisted thoracoscopic en bloc vertebrectomy for spine tumors: technique and outcomes in a series of 33 patients. J Bone Jt Surg. 2021;103(12):1104-14.
Chardack WM, MacCallum JD. Pancoast tumor. J Thorac Surg. 1956;31(5):535-542.
Shaw RR, Paulson DL, Kee JL. Treatment of the superior sulcus tumor by irradiation followed by resection:. Ann Surg. 1961;154(1):29-40.
Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg. 1993;105(6):1025-1034.
Puma F, Gili A, Cagini L, et al. Surgery for pancoast tumors-the role of combined approaches. Curr Chall Thorac Surg. 2020;2:4.
Marulli G, Battistella L, Perissinotto E, et al. Results of surgical resection after induction chemoradiation for pancoast tumours. Interact Cardiovasc Thorac Surg. 2015;20(6):805-812. Discussion 11-2.

Auteurs

Sarah Kader (S)

Division of Thoracic and Cardiovascular Surgery, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.

Ammara Watkins (A)

Division of Thoracic and Cardiovascular Surgery, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts, USA.

Elliot L Servais (EL)

Division of Thoracic and Cardiovascular Surgery, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH